Abstract
Epidermal growth factor (EGF) is a 6000 kDa peptide which exerts its biological effects by binding to a specific cell membrane receptor (EGF-R). Extensive studies on EGF-R in breast tumors have demonstrated the prognostic value of such assays. EGF-R measurement is also reportedly potentially useful in other tumors. Classically, the EGF-R content of tumor cell membrane preparations is evaluated by competition between a given concentration of labeled ligand and various concentrations of unlabeled ligand. The large quantity of tumor tissue required (approx. 0.5 g) is a serious limitation for wide-spread use of EGF-R assays. In order to validate a miniaturized EGF-R assay method, the principle of a single-dose technique (SD) using a single concentration of labeled ligand (1 nM) was investigated in the present work. Only 100–150 mg wet tissue were required for routine analysis by the SD method. The correlation between the SD method and Scatchard analysis calculated from 41 different breast carcinoma samples was very satisfactory (r = 0.973, p < 0.001). Analysis of intra-assay and inter-assay reproducibility revealed a comparable EGF-R status in given samples. The correlation between EGF-R levels and steroid receptors was investigated in 105 individual breast tumors. EGF-R levels were inversely correlated with the estradiol receptor values. No correlation was found with progesterone receptors. The simplified SD method for EGF-R measurement appears suitable for large scale clinical studies aimed at investigating the potential utility of this biological tumor marker.
References
Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237: 1555–1562, 1962
Carpenter G, Cohen S: Epidermal growth factor. Annual Rev Biochem 48: 198–216, 1979
Downward J, Yarden Y, Mayer L, Srace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarity of epidermal growth factor receptor and v-erb-b oncogene protein sequences. Nature (Lond) 307: 521–526, 1984
Liberman TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H: Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44: 753–760, 1984
Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JRC, Harris AL: Epidermal growth factor receptors in human bladder cancer: comparisons of invasive and superficial tumors. Lancet i: 366–368, 1985
Kanamori A, Abe Y, Yajima Y, Manabe Y, Ito K: Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. J Clin Endocrinol Metab 68: 899–903, 1989
Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL: Epidermal growth factor receptors in non-small-cell lung cancer. Br J Cancer 55: 513–516, 1987
Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44: 3448–3453, 1984
Peyrat JP, Bonneterre J, Vandewalle B, Djiane J, Lefebvre J: Récepteurs de l'EGF dans les cancers du sein humains. Relation avec les récepteurs hormonaux. Annales d'Endocrinologie 45: 412–413, 1984
Perez R, Pascual M, Macias A, Lage A: Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 4: 189–193, 1984
Sainsbury JRC, Farndon JR, Harris AL, Sherbet GV: Epidermal growth factor receptors on human breast cancer. Br J Surg 72: 186–188, 1985
Cowley G, Smith JA, Gusterson B, Hendler F, Ozanne B: The amount of EGF receptor is elevated on squamous cell carcinomas. In The Cancer Cell. Cold Spring Harbor. New York, 1984, p 5–10
Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL: Epidermal growth factor receptors and estrogen receptors in human breast cancer. Lancet i: 364–366, 1985
Wyss R, Fabbro D, Regazzi R, Borner C, Takahashi A, Eppenberger U: Phorbol ester and epidermal growth factor receptors in human breast cancer. Anticancer Res 7: 721–728, 1987
Sainsbury JRC, Farndon JR, Needham GK, Malcom AJ, Harris AL: Epidermal growth factor receptor status as a predictor of early recurrence of and death from breast cancer. Lancet i: 1398–1402, 1987
Skoog L, Macias A, Azavedo E, Lombardero J, Klintenberg C: Receptors for EGF and oestradiol and thymidine kinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer 54: 271–276, 1986
Pekonen F, Partanen S, Makinen T, Rutanen EM: Receptors for epidermal growth factor and insulin-like growth factor-1 and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343–1347, 1988
Battaglia F, Polizzi G, Scambia G, Rossi S, Benedetti Panici P, Iacobelli S, Crucitti F, Mancuso S: Receptors for epidermal growth factor and steroid hormones in human breast cancer. Oncology 45: 424–427, 1988
Capelletti V, Brivio M, Miodini P, Granata G, Coradini D, Di Fronzo G: Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors. Tumor Biol 9: 200–211, 1988
Foekens JA, Portengen H, Janssen M, Klijn JGM: Insulinlike growth factor-1 receptors and insulin-like growth-factor-1-like activity in human primary breast cancer. Cancer 63: 2139–2147, 1989
Delarue JC, Friedman S, Mouriesse H, May-Levin F, Sancho-Garnier H, Contesso G: Epidermal growth factor receptor in human breast cancer: correlation with estrogen and progesterone receptors. Breast Cancer Res Treat 11: 173–178, 1988
Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R, Skoog L: Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7: 459–464, 1987
Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U: Predictive value of EGF receptor in breast cancer. Lancet i: 1258, 1988
Grimaux M, Romain S, Remvikos Y, Martin PM, Magdelenat H: Prognostic value of epidermal growth factor receptor in node-positive breast cancer. Breast Cancer Res Treat 14: 77–90, 1989
Bauknecht T: The evidence and evaluation of epidermal growth factor receptors and EGF-like factors as prognostic agents in ovarian carcinoma. J Cell Biochem, suppl. 10 C: 161, 1986
Hendler F, Shum Siu A, Nanu L, Ozanne B: Overexpression of EGF receptors in squamous tumors is associated with poor survival. J Cell Biochem, suppl 12 A: 105, 1988
Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL: Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer 42: 36–41, 1988
Milano G, Moll JL, Formento JL, Francoual M, Krebs BP, Namer M, Boublil JL, Lalanne CM: Simultaneous micromeasurement of steroid receptors in breast cancer. Br J Cancer 48: 579–584, 1983
Formento JL, Moll JL, Francoual M, Krebs BP, Milano G, Renee N, Khater R, Frenay M, Namer M: HPLC micromethod for simultaneous measurement of estradiol, progesterone, androgen and glucocorticoid receptor levels. Application to breast cancer biopsies. Eur J Cancer Clin Oncol 23: 1307–1314, 1987
Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein dye binding. Anal Biochem 72: 248–254, 1976
Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672, 1949
Mc Pherson GA: A practical computer based approach to the analysis of radioligand binding experiments. Computer Prog in Biomed 17: 107–114, 1983
King AC, Cuatrecasas P: Resolution of high and low affinity growth factors. J Biol Chem 257: 3053–3060, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Formento, J.L., Francoual, M., Formento, P. et al. Epidermal growth factor receptor assay: Validation of a single point method and application to breast cancer. Breast Cancer Res Tr 17, 211–219 (1991). https://doi.org/10.1007/BF01806370
Issue Date:
DOI: https://doi.org/10.1007/BF01806370